Skip to main content
. 2020 Aug 14;10:1316. doi: 10.3389/fonc.2020.01316

Figure 1.

Figure 1

Blood biomarkers for AFP-negative hepatocellular carcinoma. ANHC, alpha-fetoprotein-negative hepatocellular carcinoma; cfDNA, circulating cell-free DNA; circRNAs, circular RNAs; DCP, des-gamma-carboxy prothrombin; AFP-L3, α-fetoprotein fraction L3; GP73, golgi protein 73; AKR1B10, aldo-keto reductase family 1 member B10; DKK1, dickkopf-1; MDK, midkine; Hsp90α, heat shock protein 90alpha; ANGPTL2, angiopoietin-like protein 2; PON1, paraoxonase 1; CAP2, cyclase-associated protein 2; CCT3, chaperonin containing TCP1 complex subunit 3; IQGAP3, IQ-motif-containing GTPase-activating protein-3; sAxl, soluble transforming receptor tyrosine kinase; OPN, osteopontin; MCM6, minichromosome maintenance complex component 6; CRP, c-reactive protein; TGM2, tissue transglutaminase 2; VASN, vasorin; HCCR-1, human cervical cancer oncogene 1; CYP17A1, the cytochrome P450, family 17, subfamily A, polypeptide 1; GS, glutamine synthetase; AGP, alpha-1 acid glycoprotein; THBS2, thrombospondin-2; IgG, immunoglobulin G; DHCR24 Ab, 3β-hydroxysterol Δ24-reductase antibody; ALP, alkaline phosphatase; ALT, alanine aminotransaminase; APTT, activated partial thromboplastin time; GGT, gamma-glutamyl transpeptidase.